Veterinary Medicines

Miloxan vakcina A.U.V.

Authorised
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
Download as PDF

Product identification

Medicine name:
Miloxan vakcina A.U.V.
Active substance:
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium sordellii, toxoid
    1.00
    90% protective dose in guinea pig
    /
    1.00
    unit(s)/dose
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    unit(s)/dose
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    unit(s)/dose
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    1.00
    unit(s)/dose
  • Clostridium chauvoei, Inactivated
    1.00
    90% protective dose in guinea pig
    /
    1.00
    unit(s)/dose
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    unit(s)/dose
  • Clostridium perfringens, type B and C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: